Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Equity Ratio (2023 - 2025)

Historic Equity Ratio for Beta Bionics (BBNX) over the last 3 years, with Q3 2025 value amounting to 0.89.

  • Beta Bionics' Equity Ratio changed N/A to 0.89 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.89, marking a year-over-year change of. This contributed to the annual value of 1.64 for FY2024, which is 1116.76% up from last year.
  • According to the latest figures from Q3 2025, Beta Bionics' Equity Ratio is 0.89.
  • In the past 5 years, Beta Bionics' Equity Ratio ranged from a high of 0.93 in Q1 2025 and a low of 1.85 during Q4 2023
  • Over the past 3 years, Beta Bionics' median Equity Ratio value was 0.89 (recorded in 2025), while the average stood at 0.15.
  • The largest annual percentage gain for Beta Bionics' Equity Ratio in the last 5 years was 1116.76% (2024), contrasted with its biggest fall of 1116.76% (2024).
  • Over the past 3 years, Beta Bionics' Equity Ratio (Quarter) stood at 1.85 in 2023, then rose by 11.17% to 1.64 in 2024, then skyrocketed by 154.47% to 0.89 in 2025.
  • Its last three reported values are 0.89 in Q3 2025, 0.91 for Q2 2025, and 0.93 during Q1 2025.